Synecor Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Synecor General Information

Description

Developer of surgical medical devices designed to drive the rapid creation of novel services for unmet needs. The company offers devices for the treatment of obesity and spine therapeutics and also age-related and lifestyle diseases, enabling patients to begin treatment quickly and resulting in a better likelihood of successful treatment.

Contact Information

Website
www.synecor.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1340 Environ Way
  • Chapel Hill, NC 27517
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Life Sciences
Corporate Office
  • 1340 Environ Way
  • Chapel Hill, NC 27517
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synecor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 10-Oct-2014 Completed Out of Business
6. Later Stage VC 30-Aug-2010 Completed Generating Revenue
5. Later Stage VC (Series D) 10-Jan-2008 Completed Generating Revenue
4. Early Stage VC (Series B) 09-Aug-2005 Completed Startup
3. Early Stage VC 16-Jan-2002 Completed Startup
2. Early Stage VC 14-Dec-2000 $10.5M $12M Completed Startup
1. Seed Round $1.5M $1.5M Completed Startup
To view Synecor’s complete valuation and funding history, request access »

Synecor Patents

  • 215

    Total Documents Applications and Grants

  • Total Patents Families

  • 65

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Synecor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220370763-A1 Antegrade steering catheter and method for delivering therapeutic devices to vavle sites of the heart Inactive 21-May-2021
US-20220183823-A1 Device and method for percutaneously delivering a tricuspid valve Active 14-Dec-2020
US-11957578-B2 Device and method for percutaneously delivering a tricuspid valve Active 14-Dec-2020
US-20210369454-A1 System and method for percutaneously delivering a tricuspid valve Inactive 10-Feb-2020
US-20210244393-A1 Steerable conduit for transseptal passage of devices to the aorta Inactive 07-Feb-2020 A61M25/0041
To view Synecor’s complete patent history, request access »

Synecor Investments (3)

Synecor’s most recent deal was a Early Stage VC with InnerPulse for . The deal was made on 27-Sep-2005.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
InnerPulse 27-Sep-2005 Early Stage VC Surgical Devices
InnerPulse 21-Nov-2003 Early Stage VC Surgical Devices
BioStent Early Stage VC Surgical Devices
To view Synecor’s complete investments history, request access »

Ready to get started?

Request a free trial

Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Synergy Life Science Partners San Francisco, CA 2006

Synecor FAQs

  • When was Synecor founded?

    Synecor was founded in 2000.

  • Where is Synecor headquartered?

    Synecor is headquartered in Chapel Hill, NC.

  • What industry is Synecor in?

    Synecor’s primary industry is Therapeutic Devices.

  • Is Synecor a private or public company?

    Synecor is a Private company.

  • What is Synecor’s current revenue?

    The current revenue for Synecor is .

  • How much funding has Synecor raised over time?

    Synecor has raised $32M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »